Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.
Erice
A
A
Department of Laboratory Medicine, University of Minnesota Medical School, Minneapolis.
Balfour
H H
HH
D000998:Antiviral Agents / Q000494:pharmacology*; D016049:Didanosine / Q000494:pharmacology; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000382:microbiology; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D018894:Reverse Transcriptase Inhibitors; D016047:Zalcitabine / Q000494:pharmacology; D015215:Zidovudine / Q000494:pharmacology
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine